Core team
Continuity, accountability, and delivery. The same people stay with the engagement from positioning through to deal progression.
About Probacure
Built around the expertise each opportunity needs
Early-stage biotech companies rarely need the same mix of business development experience at every stage. They do need continuity, sound judgement, and people who understand both the science and the realities of partnering.
Probacure combines a focused core team with our CBO Network of experienced biotech and pharma business development leaders, allowing us to build the right level of support around each programme.
Meet the team- 30+
- biotech innovators supported
- Hundreds
- of partnering and investment discussions enabled
- >$1B
- in facilitated deal value
Origin
Why we built Probacure
Probacure began with a frustration our founder first met as a PhD researcher on a drug discovery programme. Strong science did not translate into support: partners were hard to win over, grants were turned down. The problem was rarely the science, but how the opportunity looked to the people being asked to back it.
Consulting later showed him the same pattern from another angle. Promising programmes stalled and companies went out of business even where the science and the market were not the problem. Strategy, positioning, and commercialisation were.
That shaped Probacure: help companies understand what stakeholders need to see, reach the right people, and draw on business development expertise without building it internally. And because no two programmes need the same mix of insight, therapeutic knowledge, and transaction experience, we built a focused core team with a CBO Network behind it.
The model
A consistent core team. Broader experience when it matters
Your Probacure core team stays close to the engagement, providing continuity across strategy, research, outreach, and deal progression. Where a programme benefits from additional senior expertise, we can add experienced specialists from our CBO Network, selected for the needs of the asset, transaction, therapeutic area, or market.
CBO Network
Specialist depth, senior deal experience, and additional reach, added around the engagement when the background is relevant to the programme.
CBO Network
Senior experience, added around the opportunity
No two partnering programmes require exactly the same experience. We maintain an active network of experienced biotech and pharma business development professionals who can be brought into engagements where their background adds value.
Representative anonymised profiles from our CBO Network. Individual specialists are matched to engagements based on relevant experience, availability, and fit.
In practice
One engagement. The right expertise around it
The core team remains accountable for the engagement. Additional capability is brought in selectively, where it is relevant to the programme.
Understand the programme
We define the strategic, commercial, and execution needs of the engagement.
Add relevant capability
Senior specialists where their background fits, and the network, tools, and market data the programme needs to move.
Work as one team
The client has a clear Probacure point of accountability while benefiting from broader expertise behind the engagement.
Collective capability
Experience that extends beyond the core team
The CBO Network
Former founders, biotech executives, former CBOs, and ex-pharma professionals: people who have sat on the other side of the table and know what has to be true before a partner moves.
Access
Between the core team and the CBO Network, we can reach the major markets where partnering, licensing, and investment decisions are made.
Execution
Deal experience built over full careers in pharma and biotech: running processes, preparing for diligence, and getting terms agreed.
>$75Bcollectively facilitated in deal value across the core team and CBO Network
Principles
How we work
The engagement should fit the stage.
Some companies need a defined piece of work: positioning, a target list, a partnering push. Others need ongoing BD leadership in the seat month after month. We shape the engagement around where the programme is, what it needs next, and what the budget allows, then build the right expertise around it.
Access only counts if it is relevant.
A large network is not the point; reaching the people who can act on your programme is. Between the core team and the CBO Network, we work to reach decision-makers aligned to the therapeutic area, the modality, and the markets where a deal is realistic.
Market feedback should change the strategy.
Real conversations generate information. We use that feedback to refine positioning, priorities, and the next step.
Selected proof
Who we've worked with
We've worked together with a range of organisations across the globe to support their goals of breaking new ground in biotech innovation.
Build the BD capability your programme needs
Whether you need focused strategic support, targeted business development, or ongoing fractional BD leadership, we can build the right level of support around the opportunity.